Neurogenic orthostatic hypotension in Parkinson’s disease: evaluation, management, and emerging role of droxidopa

por Isaacson, Stuart H, Skettini, Julia
Publicado 2014

Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios

por Isaacson, Stuart H, Betté, Sagari, Pahwa, Rajesh
Publicado 2022

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease

por Bergmans, Bruno, Clark, Veronica, Isaacson, Stuart H., Bäumer, Tobias
Publicado 2023

Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson’s Disease Psychosis

por Isaacson, Stuart H., Coate, Bruce, Norton, James, Stankovic, Srdjan
Publicado 2020

Tardive Dyskinesia in Older Persons Taking Antipsychotics

por Citrome, Leslie, Isaacson, Stuart H, Larson, Danielle, Kremens, Daniel
Publicado 2021

Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson’s Disease

por Isaacson, Jonathan R., Brillman, Salima, Chhabria, Nisha, Isaacson, Stuart H.
Publicado 2021

Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension

por Isaacson, Stuart H., Dashtipour, Khashayar, Mehdirad, Ali A., Peltier, Amanda C.
Publicado 2021

Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoring

por Isaacson, S.H., Pahwa, R., Pappert, E.J., Torres-Russotto, D.
Publicado 2022

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?

por Isaacson, Stuart H., Pagan, Fernando L., Lew, Mark F., Pahwa, Rajesh
Publicado 2022

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature

por Isaacson, Stuart H., Dewey, Richard B., Pahwa, Rajesh, Kremens, Daniel E.
Publicado 2022

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment

por Isaacson, Stuart H., Hauser, Robert A., Pahwa, Rajesh, Gray, David, Duvvuri, Sridhar
Publicado 2023

Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo(®) 200) in the treatment of Parkinson’s disease: a case series

por Sethi, Kapil D, Hauser, Robert A, Isaacson, Stuart H, McClain, Terry
Publicado 2009

Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension

por Hauser, Robert A., Heritier, Stephane, Rowse, Gerald J., Hewitt, L. Arthur, Isaacson, Stuart H.
Publicado 2016

Correction to: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel

por Pahwa, Rajesh, Isaacson, Stuart H., Small, Gary W., Torres-Yaghi, Yasar, Pagan, Fernando, Sabbagh, Marwan
Publicado 2023

Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel

por Pahwa, Rajesh, Isaacson, Stuart H., Small, Gary W., Torres-Yaghi, Yasar, Pagan, Fernando, Sabbagh, Marwan
Publicado 2022

Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary?

por Hauser, Robert A., Ondo, William G., Zhang, Yi, Bowling, Alyssa, Navia, Bradford, Pappert, Eric, Isaacson, Stuart H.
Publicado 2023

Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: R...

por Agbo, Felix, Isaacson, Stuart H., Gil, Ramon, Chiu, Yu-Yuan, Brantley, Scott J., Bhargava, Parul, Navia, Bradford
Publicado 2021

Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment

por Hauser, Robert A., Favit, Antonella, Hewitt, L. Arthur, Lindsten, Annika, Gorny, Stephen, Kymes, Steven, Isaacson, Stuart H.
Publicado 2022

Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations

por Jackson, Richard, Brams, Matthew N, Citrome, Leslie, Hoberg, Amber R, Isaacson, Stuart H, Kane, John M, Kumar, Rajeev
Publicado 2021

Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson’s Disease

por Brillman, Salima, Khemani, Pravin, Isaacson, Stuart H., Pahwa, Rajesh, Deshpande, Ruta, Zraick, Vivien, Rajagopal, Apoorva, Khosla, Dhira, Rosenbluth, Kathryn H.
Publicado 2023